A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Women
Status:
COMPLETED
Trial end date:
2025-05-12
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the concentration of rozanolixizumab in mature breast milk of healthy study participants following administration of a single dose of rozanolixizumab